MRC Study of carcinoma in situ of the contralateral testis

ISRCTN ISRCTN37957513
DOI https://doi.org/10.1186/ISRCTN37957513
Secondary identifying numbers TE11
Submission date
08/02/2001
Registration date
08/02/2001
Last edited
18/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Pat Cook
Scientific

MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Email pat.cook@ctu.mrc.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesTo ascertain the prevalence of CIS of testis in this group of patients.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer
InterventionAll subjects biopsied. Positive biopsy: optional randomisation between radiotherapy or surveillance. Negative biospy: surveillance.
Intervention typeOther
Primary outcome measureDetermine prevalence of CIS and the development of invasive tumour.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1989
Completion date31/12/1995

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexMale
Target number of participants208
Key inclusion criteria1. Germ cell tumour of testis or history of one having been excised in the previous five years
2. History of maldescent
3. Volume of 12 ml or less in remaining testis
Key exclusion criteriaPrevious chemotherapy
Date of first enrolment01/01/1989
Date of final enrolment31/12/1995

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Sponsor information

Medical Research Council (MRC) (UK)
Research council

20 Park Crescent
London
W1B 1AL
United Kingdom

Phone +44 (0)20 7636 5422
Email clinical.trial@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk

Funders

Funder type

Research council

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/1998 Yes No